The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Disclosed in a recent SEC filing on January 28, Martha, Chairman and CEO at Medtronic MDT, made a noteworthy transaction involving the exercise of company stock options. What Happened: Disclosed ...

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 2:15 p.m. PST (4:15 p.m. CST). Immediately following ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

In a news release, CEO Geoff Martha said, “Thierry is a strategic, creative, operationally focused, experienced CFO with a proven track record of delivering innovation-driven growth, margin ...

Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...